Acute, refractory Graft Versus Host Disease

Also known as: Refractory Acute graft-versus-host disease / Acute, refractory Graft-versus-host disease

DrugDrug NameDrug Description
DB13973Remestemcel-LIndicated for in the management of acute Graft versus Host Disease (aGvHD) in pediatric patients. Acute GvHD should be refractory to treatment with systemic corticosteroid therapy and/or other immunosuppressive agents....
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount